MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
15.67
-0.54 (-3.33%)
At close: Jan 30, 2026, 4:00 PM EST
15.92
+0.25 (1.60%)
After-hours: Jan 30, 2026, 7:54 PM EST
MLTX Market Cap
MLTX has a market cap or net worth of $1.12 billion as of January 30, 2026. Its market cap has decreased by -61.86% in one year.
Market Cap
1.12B
Enterprise Value
813.67M
1-Year Change
-61.86%
Ranking
Category
Stock Price
$15.67
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.12B, an increase of 30,983.92%. That is a compound annual growth rate of 326.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 1.16B | 22.99% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 1.18B |
| Day One Biopharmaceuticals | 1.15B |
| Compass Therapeutics | 1.14B |
| Inventiva | 1.13B |
| Capricor Therapeutics | 1.13B |
| EyePoint | 1.12B |
| Inhibrx Biosciences | 1.11B |
| AbCellera Biologics | 1.08B |